Align Technology’s 16.92 P/E and 1.68 PEG Ratios Offer Superior Value
Align Technology’s forward P/E ratio is 16.92, PEG ratio 1.68 and P/B ratio 3.35, compared with West Pharmaceutical Services’ 31.93, 2.71 and 5.7 respectively. These metrics yield a Value grade of B for Align versus D for West, positioning Align as the superior value option.
1. Valuation Metric Comparison
Align Technology’s forward P/E ratio stands at 16.92 versus 31.93 for West Pharmaceutical Services, while its PEG ratio of 1.68 contrasts with West’s 2.71. Align’s P/B ratio of 3.35 also undercuts West’s 5.7, reflecting lower price relative to book value.
2. Value Grade Outcome
These relative valuations translate into a Value grade of B for Align, compared with D for West. Investors seeking undervalued opportunities thus find Align Technology the superior option based on these traditional metrics.